Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSabre Insurance Group Regulatory News (SBRE)

Share Price Information for Sabre Insurance Group (SBRE)

Share Price is delayed by 15 minutes
Get Live Data
172.40    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 1.60 (0.928%)
Market Cap: £419.49m
SBRE Live PriceLast checked at - London Stock Exchange

Intraday Sabre Insurance Group Share Chart

Trading Update

24 May 2018 07:00

RNS Number : 0930P
Sabre Insurance Group PLC
24 May 2018
 

24 May 2018

 

SABRE INSURANCE GROUP PLC

Trading Update

Sabre Insurance Group plc (the "Group", or "Sabre"), one of the UK's leading private motor insurance underwriters, today publishes a trading update ahead of its AGM to be held later this morning.

Summary

· As set out in our 2017 full year results, in common with the rest of the motor market, we experienced competitive pricing in the last few weeks of 2017 which continued into the first two months of 2018 resulting in a modest reduction in premium income relative to the same period in 2017

 

· Pricing action was taken in early March to reflect the improving claims trends, specifically lower whiplash claims frequency, which has resulted in gross written premium ("GWP") returning to approximately 2017 levels on a weekly run-rate basis with no deterioration in our expected underwriting margins. Given this GWP for the year to 30 April 2018 is down year on year by around 5% at £69.8m(1) (2017: £73.1m(1))

 

· The Group continues to deliver leading underwriting performance supported by positive claims experience in the early months of 2018, and therefore reiterates the full year guidance for the 2018 underwriting performance reflecting a combined ratio slightly better than our long-term target of mid-70%'s

 

· A solvency ratio of over 188%(1) at the end of March exceeds our 140% - 160% target corridor, with organic capital being generated on a monthly basis

Geoff Carter, CEO, commented:

"Profitability of business written remains our key priority, with gross written premium and growth being an output rather than a target. Whilst we saw a reduction in premium income in the first two months of the year relative to the equivalent period last year, we took pricing action in early March which was supported by the emerging claims data. Following this action, volumes of new business on a weekly run-rate basis have returned to similar levels as the equivalent period in 2017 without any deterioration in expected underwriting margins. As such we remain confident in performing slightly better than our mid-70%'s combined ratio target for 2018, given our claims experience to date.

The motor market remains in a choppy state as competitors react to the early signs of changing claims patterns. Much uncertainty remains on the end state of these changes, not least around the critical Ogden discount rate which may impact overall claim costs and reinsurance pricing, making it difficult to predict the outcome for pricing and volumes for the remainder of the year and beyond. However, the market appears to have reacted rationally to reflect real-world changes in the cost of claims. Since we undertook our pricing action earlier this year we have seen no significant change in the pricing environment in our sector and, as such, currently expect our 2018 GWP position to be broadly in line with 2017. Assuming no changes to the current environment, we would expect modest GWP growth in 2019, without deterioration from our current underwriting margins.

In summary, we are encouraged by the start to the year. We remain absolutely committed to our core principle of underwriting discipline over GWP growth. We believe this will deliver a strong underwriting performance, and allow us to continue strengthening our capital position which will support the delivery of an attractive dividend, in line with our policy (stated at the time of the IPO) of paying out surplus capital by way of ordinary and special dividends."

(1) Numerical information not subject to audit

Media enquiries

Tulchan Communications LLP

James Macey White, Roger Tejwani & David Ison

020 7353 4200

sabre@tulchangroup.com

Investor enquiries

Sabre Insurance Group plc

Geoff Carter & Adam Westwood

0330 024 4696

adam.westwood@sabre.co.uk

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTSEDFMDFASEFI
Date   Source Headline
14th Jul 20257:00 amRNSTransaction in Own Shares
11th Jul 202510:55 amRNSDirector/PDMR Shareholding
11th Jul 20257:00 amRNSTransaction in Own Shares
10th Jul 20257:00 amRNSTransaction in Own Shares
9th Jul 20257:00 amRNSTransaction in Own Shares
8th Jul 20257:00 amRNSTransaction in Own Shares
7th Jul 20257:00 amRNSTransaction in Own Shares
4th Jul 20257:00 amRNSTransaction in Own Shares
3rd Jul 20257:00 amRNSTransaction in Own Shares
2nd Jul 20257:00 amRNSTransaction in Own Shares
1st Jul 20257:00 amRNSTransaction in Own Shares
17th Jun 20254:35 pmRNSDirector/PDMR Shareholding
11th Jun 20251:38 pmRNSDirector/PDMR Shareholding
5th Jun 202511:16 amRNSDirector/PDMR Shareholding
22nd May 202511:38 amRNSResult of AGM
22nd May 20257:00 amRNSTrading Update
13th May 20253:18 pmRNSDirector/PDMR Shareholding
17th Apr 20259:40 amRNSDirector/PDMR Shareholding
11th Apr 20251:26 pmRNSDirector/PDMR Shareholding
10th Apr 20251:09 pmRNSDirector/PDMR Shareholding
8th Apr 20254:31 pmRNSDirector/PDMR Shareholding
8th Apr 20253:54 pmRNSDirector/PDMR Shareholding
8th Apr 20251:53 pmRNSDirector/PDMR Shareholding
4th Apr 20253:20 pmRNSNotice of AGM
27th Mar 20258:37 amRNSDirector/PDMR Shareholding
20th Mar 202511:39 amRNSDirector/PDMR Shareholding
18th Mar 20257:00 amRNSFinal Results
11th Mar 20251:21 pmRNSDirector/PDMR Shareholding
24th Feb 202511:23 amRNSNotice of Results
11th Feb 20253:12 pmRNSDirector/PDMR Shareholding
13th Jan 20252:14 pmRNSDirector/PDMR Shareholding
11th Dec 202411:57 amRNSDirector/PDMR Shareholding
5th Dec 20247:00 amRNSCapital Markets Event
21st Nov 202410:28 amRNSAppointment of Joint Corporate Broker
12th Nov 20241:15 pmRNSDirector/PDMR Shareholding
23rd Oct 20244:13 pmRNSHolding(s) in Company
22nd Oct 20242:43 pmRNSDirector/PDMR Shareholding
22nd Oct 20242:40 pmRNSDirector/PDMR Shareholding
22nd Oct 20247:00 amRNSTrading Update
18th Oct 20243:25 pmRNSHolding(s) in Company
11th Oct 202412:40 pmRNSDirector/PDMR Shareholding
26th Sep 20241:25 pmRNSDirector/PDMR Shareholding
11th Sep 202412:21 pmRNSDirector/PDMR Shareholding
11th Sep 20249:51 amRNSHolding(s) in Company
6th Sep 20242:29 pmRNSHolding(s) in Company
30th Aug 202411:50 amRNSDirector/PDMR Shareholding
22nd Aug 20244:22 pmRNSHolding(s) in Company
14th Aug 20243:33 pmRNSHolding(s) in Company
13th Aug 202412:48 pmRNSDirector/PDMR Shareholding
30th Jul 20247:00 amRNSHalf-year Report 2024

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.